GFAP and amyloidosis: The discrepancy between CSF and plasma hereby further underlines the theory that plasma levels might be more closely related to amyloid status due to an amyloid-dependent, direct secretion of GFAP into the bloodstream by astrocytic end feet, whereas CSF GFAP might respond to events in later disease stages, eg, neuroinflammation.49